This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.
More than 40 years of health innovation
PATH has been in Vietnam since 1980, working alongside leaders, communities, and local change makers to develop sustainable systems for tackling the country’s shifting health challenges. Whether we are enabling health care providers to deliver high-quality services or enhancing digital systems to detect and respond to disease outbreaks, our innovations improve health outcomes for the Vietnamese population.
Multilateral COVID-19 response
With well-established networks and expertise, PATH rapidly pivoted resources to respond to COVID-19, supporting local vaccine development, strengthening surveillance through an online tracking system, and improving availability of medical oxygen and respiratory equipment. PATH also worked closely with partners to shift to online order and delivery of antiretroviral drugs and HIV testing kits, ensuring continuity of HIV care throughout COVID-19 restrictions.
Human-centered care for NCDs
PATH prioritizes digital health innovations to increase health care access and affordability for noncommunicable diseases (NCDs) such as cancer or diabetes. Our unique approach brings together community participation, cross-sectoral collaboration, human-centered design, and social media to deliver sustainable, scalable NCD prevention programs.
PATH in Vietnam works with local communities and the private sector to ensure the HIV and tuberculosis (TB) response meets the needs of populations facing the greatest risks. Together with partners such as the Vietnam Administration for HIV/AIDS Control and the Global Fund, we introduce innovative tools and approaches for prevention, detection, and treatment of HIV, TB, and viral hepatitis; build business capacity for community-based organizations to provide sustainable and client-centered services; and use social and behavior change communication to reach key affected populations. Our HIV/TB team does not fear disrupting the market—instead, we welcome the opportunity to challenge the status quo and redefine service delivery models.
Since 1994, PATH has been working with national immunization programs in Vietnam, Laos, Cambodia, and Myanmar for elimination of vaccine-preventable diseases, including hepatitis B, rotavirus, Japanese encephalitis, and seasonal and pandemic influenza. PATH’s strategy focuses on strengthening immunization systems and data, accelerating local vaccine production and introduction of new vaccines, expanding coverage of underutilized vaccines, and demonstrating innovations in vaccine supply chains, medical waste management, and immunization information systems. As a trusted partner of Vietnam’s Ministry of Health, we are now facilitating and supporting the rollout of COVID-19 vaccines and COVID-19 vaccine development.
We support Vietnam’s Ministry of Health, public and private partners, and communities to develop and implement models of decentralized testing, care, and treatment for HIV, TB, viral hepatitis, and noncommunicable diseases (NCDs). Examples include HIV lay testing and self-testing, and community-based screening and treatment for NCDs and pediatric TB. Such models are critical to embedding essential health services into primary health care systems to accelerate the attainment of health for all.
Public health threats know no borders and neither do we. PATH in Vietnam is committed to accelerating action for stronger epidemic preparedness across the country and the region. By building on existing capacities, coordinating with regional partners, and developing sustainable digital models for epidemic preparedness, PATH leads global health security efforts in the region and provides technical support to neighboring countries to enhance health equities across Southeast Asia.
We harness our 40+ years of expertise in Vietnam to analyze markets and catalyze interventions toward achieving sustainable access to affordable, quality-assured diagnostic tools and malaria treatment. PATH, in collaboration with Medicines for Malaria Venture, supports the National Institute of Malariology, Parasitology, and Entomology (NIMPE) in introducing new medicines and diagnostics for Plasmodium vivax malaria and integrating G6PD diagnostics into the National Strategic Plan for malaria. This work has led to an operations research study on G6PD diagnostics by PATH and NIMPE to promote the adoption of new diagnostics.
Our primary office is in Hanoi.
Address
#1101, 11th Floor, Hanoi Towers, 49 Hai Ba Trung
Hoan Kiem District, Hanoi, Vietnam
Phone: +84 24 3936 2215
We also have an office in Ho Chi Minh City.
#723-3, 7th floor, Regus Office, Melinh Point Tower, 2 Ngo Duc Ke
District 1, Ho Chi Minh City, Vietnam
Phone: +84 28 3520 2912
Dr. Nguyen Tuyet Nga
Director, Southeast Asia Hub
Dr. Kimberly Green
Global Program Director, Primary Health Care
Dr. Vu Minh Huong
Regional Technical Advisor, CVIA Policy, Access, and Introduction Functional Area
Dr. Nguyen To Nhu
Program Director, Global Health Security
Hoang Thi Thu Huong
Operations Manager
Dr. Le Hien
Program Director, Noncommunicable Diseases
Dr. Vu Ngoc Bao
Deputy Program Director, HIV/TB
